Lab Reference Library / SIBO Breath Test Gut & Immune

SIBO Breath Test

Q: What is a positive SIBO breath test?

Positive criteria vary slightly by laboratory, but broadly: hydrogen-dominant SIBO is positive when exhaled H2 rises 20 ppm or more above baseline within 90 minutes on lactulose substrate, or 12 ppm or more on glucose substrate. Methane-dominant SIBO (intestinal methanogen overgrowth) is positive when CH4 reads 10 ppm or above at any point during the test regardless of rise. Hydrogen sulfide SIBO has emerging positive criteria; a flat-line pattern on standard breath testing (no H2 or CH4 rise) with SIBO symptoms is suspicious.

Q: What is the difference between hydrogen and methane SIBO?

Hydrogen-dominant SIBO is produced by fermentative bacteria (Escherichia, Klebsiella, Bacteroides species) overgrown in the small intestine; it typically presents with diarrhea-predominant symptoms. Methane-dominant SIBO (now called intestinal methanogen overgrowth or IMO) is produced by archaea (primarily Methanobrevibacter smithii); methane slows intestinal transit and typically presents with constipation-predominant symptoms. Treatment protocols differ significantly: hydrogen SIBO responds well to rifaximin; methane SIBO requires rifaximin combined with neomycin or high-dose berberine.

Q: What causes SIBO to develop?

The primary protective mechanisms against SIBO are gastric acid (kills ingested bacteria before they reach the small intestine), migrating motor complex activity (the housekeeping waves that sweep bacteria from the small intestine between meals), and ileocecal valve integrity (preventing colonic bacteria from backflowing). SIBO develops when these defenses fail: proton pump inhibitor use and hypochlorhydria (reduce gastric acid), opioid medications and diabetes-related autonomic neuropathy (impair MMC function), and structural ileocecal abnormalities allow bacterial displacement into the small bowel.

SIBO Breath Test · Lactulose Hydrogen · Glucose Breath Test

Reference ranges, positive test criteria, and why the SIBO breath test measures hydrogen, methane, and hydrogen sulfide gas produced by bacteria displaced into the small intestine, how each gas pattern corresponds to distinct clinical presentations, and evidence-based eradication and prevention strategies.

Bacterial OvergrowthGI Motility

H2 PositiveAbove 20 ppm rise

CH4 PositiveAbove 10 ppm

H2S PositiveEmerging cutoffs

Unitsppm gas

← Back to Lab Reference Library

Category: Gut & Immune | Also known as: Hydrogen Breath Test, Lactulose Breath Test, Methane Breath Test

1. What This Test Measures

The SIBO breath test detects small intestinal bacterial overgrowth by measuring exhaled gases produced when bacteria in the small intestine ferment an ingested substrate.^[1]^[2] In a healthy small intestine, bacterial concentrations are low (below 10^3 colony-forming units per mL of intestinal fluid), maintained by gastric acid, bile, pancreatic enzymes, normal intestinal motility, and the migrating motor complex (MMC). When SIBO develops, bacterial concentrations in the small intestine rise to 10^5 CFU/mL or higher, and these bacteria ferment carbohydrates before the gut can absorb them, producing hydrogen (H2), methane (CH4), and hydrogen sulfide (H2S) gases. These gases diffuse across the intestinal wall into the portal circulation, reach the lungs, and are exhaled in concentrations that can be measured by the breath test apparatus.

The test is performed after a 24 to 48 hour preparatory diet (low-fermentable foods to clear residual substrate from the colon) and a 12-hour overnight fast. The patient drinks a substrate solution (lactulose, which is not absorbed and reaches the colon, or glucose, which is absorbed in the proximal small intestine) and exhales into collection tubes every 15 to 20 minutes for 90 to 180 minutes. Gas concentration patterns over time reveal the location and type of bacterial overgrowth.

2. Gas Patterns and Positive Criteria

Gas Type	Positive Criterion (Lactulose)	Clinical Pattern	Dominant Organisms
Hydrogen (H2)	Rise of 20 ppm or more above baseline within 90 min	Diarrhea-predominant; bloating; IBS-D pattern	Escherichia coli, Klebsiella, Bacteroides, fermentative bacteria
Methane (CH4)	10 ppm or more at any point during test	Constipation-predominant; slow transit; IMO pattern	Methanobrevibacter smithii (archaea); not technically bacteria
H2S (Hydrogen Sulfide)	Emerging cutoffs; flat-line with symptoms suspicious	Diarrhea; urgency; flatulence; rotten egg odor	Desulfovibrio, Bilophila wadsworthia, sulfate-reducing bacteria
Dual positive (H2+CH4)	Both criteria met	Mixed bowel pattern; both diarrhea and constipation	Mixed fermentative and methanogenic overgrowth

Methane-dominant SIBO is now more accurately termed intestinal methanogen overgrowth (IMO) because methanogens are archaea rather than bacteria^[2] and can be present throughout the GI tract, not only the small intestine. Lactulose substrate reaches the colon and can produce a colonic gas peak; the timing of the gas rise (within 90 minutes suggests small intestinal origin) is important for interpreting results. Glucose substrate is absorbed before reaching the colon, making a positive result more specifically indicative of proximal small intestinal overgrowth, but it misses mid and distal small intestinal SIBO.

3. What Causes SIBO to Develop

Impaired migrating motor complex (MMC): the MMC produces the interdigestive housekeeping contractions that sweep bacteria from the small intestine into the colon between meals every 90 to 120 minutes; any condition impairing MMC function allows bacteria to accumulate; causes include prokinetic medication deficiency, diabetes-related autonomic neuropathy (vagal dysfunction impairs MMC), hypothyroidism (slow gut transit), opioid medications (suppress MMC through mu-receptor activation), and post-infectious dysmotility following gastroenteritis (particularly with Cytolethal Distending Toxin-producing organisms)
Hypochlorhydria and PPI use: gastric acid kills the majority of bacteria ingested with food; without adequate acid, bacteria survive transit into the small intestine; proton pump inhibitor use is one of the most consistent risk factors for SIBO; H2 blocker use carries lower but still meaningful risk; autoimmune gastritis and atrophic gastritis producing achlorhydria carry very high SIBO risk
Ileocecal valve dysfunction: the ileocecal valve normally prevents backflow of colonic bacteria into the ileum; when incompetent, the trillions of bacteria in the colon can reflux into the small intestine, producing SIBO
Structural abnormalities: strictures, adhesions from abdominal surgery, intestinal diverticula (particularly jejunal diverticulosis), blind loops, and fistulas create stagnant intestinal areas where bacteria accumulate; post-surgical anatomy is one of the most predictable SIBO risk factors
Post-infectious IBS (PI-IBS): acute gastroenteritis with food poisoning organisms producing cytolethal distending toxin (CDT, produced by Campylobacter, Salmonella, E. coli) damages the interstitial cells of Cajal that regulate MMC activity; this is now established as the mechanism for a significant proportion of post-infectious IBS and SIBO cases
Celiac disease: ongoing small intestinal inflammation from undiagnosed or poorly controlled celiac disease promotes bacterial overgrowth through mucosal damage, impaired motility, and reduced antimicrobial peptide production
Immunodeficiency states: selective IgA deficiency, common variable immunodeficiency, and HIV-related immunosuppression reduce the mucosal immune defense against small intestinal bacterial colonization

4. Symptoms of SIBO by Gas Type

Hydrogen-Dominant SIBO

Bloating and abdominal distension, typically worse after meals and improving with fasting
Diarrhea or loose stools, often urgency-driven
Excessive flatulence, particularly after carbohydrate-containing meals
Abdominal cramping and pain
Nausea, particularly postprandial
Nutrient malabsorption: fat-soluble vitamins, B12 (bacterial consumption), and iron (bacterial competition)
IBS-D pattern: alternating diarrhea with normal stools; rarely constipation-predominant

Methane-Dominant IMO

Constipation-predominant bowel pattern; often severe, refractory to standard laxatives
Abdominal distension that worsens throughout the day
Slower transit time: methane gas directly slows intestinal smooth muscle contractility, producing the pathognomonic constipation pattern
Less acute postprandial bloating than hydrogen SIBO; more persistent baseline distension
Association with insulin resistance and obesity in emerging research
Often misdiagnosed as idiopathic constipation or IBS-C; standard laxative response is poor compared to response to methane-targeting eradication

5. Eradication and Prevention Protocols

Pharmaceutical Eradication

Hydrogen-dominant SIBO: rifaximin 550mg three times daily for 14 days is the gold standard; 77% eradication rate; gut-targeted antibiotic with minimal systemic absorption and low resistance risk; FDA-approved for IBS-D
Methane-dominant IMO: rifaximin 550mg three times daily PLUS neomycin 500mg twice daily for 14 days; neomycin targets the archaea that rifaximin alone does not adequately address; eradication rate 67 to 87%; confirm eradication with breath test 4 to 6 weeks post-treatment
Hydrogen sulfide SIBO: bismuth subsalicylate (Pepto-Bismol equivalent) combined with rifaximin is increasingly used; bismuth directly inhibits sulfate-reducing bacteria; treatment protocols are less standardized than for H2 and CH4
Always confirm eradication with breath test 4 to 6 weeks after completing antibiotics; re-treatment may be required for partial responders

Herbal Eradication Protocols

Herbal antimicrobial protocol (Crespin-Pimentel protocol equivalents): allicin (garlic-derived), berberine, oregano oil, and neem or candibactin combinations; clinical trial data shows comparable eradication to rifaximin for hydrogen-dominant SIBO; preferred for patients unable or unwilling to use antibiotics
Berberine (1,500mg daily in divided doses): particularly effective for methane-dominant IMO alongside allicin; berberine has direct antimicrobial activity against archaea; one of the most evidence-supported natural SIBO agents
Allicin (allyl sulfide from garlic; 450mg three times daily): the most consistently effective herbal agent for methane-producing archaea; must use stabilized allicin extract, not raw garlic; combine with berberine for methane patterns
Duration: 4 to 6 weeks for herbal protocols (longer than pharmaceutical); confirm eradication with breath test; 40 to 80% eradication rates comparable to rifaximin in head-to-head trials

Prevention and Relapse Prevention

Prokinetics (most critical for relapse prevention): restoring MMC function between meals is the most important relapse prevention strategy; low-dose naltrexone (1.5 to 4.5mg at bedtime), ginger (1 to 2g daily), iberogast, and 5-HTP (50mg at bedtime) are the most evidence-supported prokinetics; pharmaceutical prokinetics (prucalopride, metoclopramide) when clinically warranted
Elemental diet (2 to 3 weeks): the most effective short-term elimination diet for SIBO; pre-digested nutrients absorbed in the proximal small intestine before bacteria can ferment them; simultaneously starves bacteria and allows mucosal healing; 85% symptom improvement rate; used as alternative or adjunct to antimicrobials
Low-FODMAP diet maintenance: reduces fermentable substrate available to residual bacteria; not a cure but reduces symptom burden and may slow bacterial regrowth; use as bridge therapy, not indefinitely
Address the root cause: SIBO will reliably recur if the underlying predisposing factor (PPI use, MMC dysfunction, structural abnormality, hypothyroidism, ileocecal valve incompetence) is not identified and corrected
Identify and address post-infectious etiology: if SIBO followed food poisoning, anti-CdtB antibody testing and low-dose naltrexone targeting the autoimmune MMC damage may be required for durable resolution

6. Related Lab Tests

ZonulinSIBO Increases Intestinal Permeability via LPS

→

Fecal CalprotectinMucosal Inflammation from Bacterial Overgrowth

→

Vitamin B12SIBO Bacteria Consume B12; Monitor Deficiency

→

TSHHypothyroidism Slows MMC; Common SIBO Predisposing Factor

→

FerritinSIBO Bacteria Compete for Dietary Iron

→

Organic Acids (OAT)Microbial Metabolite Markers Reflect SIBO Pattern

→

7. Clinical Perspective

Clinical Perspective

SIBO is the most commonly missed diagnosis in patients who have been told they have IBS for years without meaningful improvement. The breath test changed my practice because it gave me an objective, reproducible way to confirm or rule out bacterial overgrowth before committing to treatment, and the gas pattern changes the treatment completely. A patient with hydrogen-dominant SIBO gets rifaximin or herbal antimicrobials followed by prokinetics. A patient with methane-dominant IMO needs rifaximin combined with neomycin or high-dose berberine, and the constipation that has failed every laxative for a decade often resolves within 2 to 4 weeks of effective methane eradication because you have removed the organism that was pharmacologically slowing their intestinal transit. The piece most practitioners miss is the relapse piece: without identifying why the MMC was impaired in the first place and restoring it with prokinetics, most SIBO patients recur within 3 to 6 months. Treating SIBO without treating the root cause is like bailing a boat without finding the hole.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

8. Frequently Asked Questions

What is a positive SIBO breath test?

A hydrogen-dominant positive result requires an H2 rise of 20 ppm or more above baseline within 90 minutes on lactulose substrate.^[2] A methane-dominant positive (intestinal methanogen overgrowth) requires CH4 of 10 ppm or more at any point during the test regardless of rise. Hydrogen sulfide SIBO has emerging but less standardized criteria; a flat-line pattern on standard testing with consistent symptoms is clinically suspicious.

What is the difference between hydrogen and methane SIBO?

Hydrogen-dominant SIBO is caused by fermentative bacteria and typically produces diarrhea-predominant symptoms, bloating, and excess gas. Methane-dominant IMO is caused by methanogenic archaea (primarily Methanobrevibacter smithii) and characteristically produces constipation-predominant symptoms because methane gas directly slows intestinal motility. Treatment differs significantly: hydrogen SIBO responds to rifaximin alone; methane IMO requires rifaximin combined with neomycin or high-dose berberine.

What causes SIBO to develop?

SIBO develops when the normal protective mechanisms fail: impaired migrating motor complex activity^[6] (the between-meal cleaning waves that sweep bacteria from the small intestine), hypochlorhydria from PPI use or atrophic gastritis (acid kills ingested bacteria before they reach the small intestine), ileocecal valve dysfunction (allows colonic bacteria to reflux), structural abnormalities from prior surgery, post-infectious MMC damage following food poisoning, hypothyroidism, and diabetes-related autonomic neuropathy.

How long does SIBO treatment take?

Pharmaceutical protocols (rifaximin, neomycin) are typically 14 days.^[5] Herbal protocols require 4 to 6 weeks. Eradication should be confirmed by repeat breath test 4 to 6 weeks after completing treatment, not before, to allow the gut to normalize. Without prokinetic therapy after eradication to restore MMC function, most patients experience SIBO relapse within 3 to 6 months regardless of which eradication protocol was used.

Why does SIBO keep coming back?

Recurrent SIBO almost always indicates that the underlying predisposing condition has not been addressed.^[3] The most common reasons are: continued PPI use reducing gastric acid, untreated MMC dysfunction requiring prokinetic therapy, unaddressed hypothyroidism slowing gut transit, ileocecal valve incompetence allowing colonic reflux, structural intestinal abnormalities, or dietary patterns providing ongoing high-fermentable substrate. Eradication without root cause identification produces short-term improvement but reliable relapse.

Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.

SIBO is one of the most common missed diagnoses in chronic GI patients. The breath test identifies it. The root cause determines whether it stays gone.

SIBO evaluation is a core part of the functional medicine gut assessment. Schedule a consultation for a complete GI workup including SIBO breath testing and root cause analysis.

Schedule a Consultation

References and Further Reading

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.